RN Mobile Menu

Search form


Arthritis Tracking Web and Mobile App Hits Recruitment Mark

Arthritis Tracking Web and Mobile App Hits Recruitment Mark

ArthritisPower™, the first-ever patient-led, patient-centered research registry for joint, bone, and inflammatory skin conditions, successfully completed enrolling 11,000 patients who have arthritis, announced CreakyJoints®, a patient resource.

Doing so fulfilled one of its primary contract requirements with the Patient-Centered Outcomes Research Institute (PCORI) more than 12 months ahead of schedule.

ArthritisPower is a free science-based, privacy-protected web and mobile app for iPhone and Android devices that allows patients to track their symptoms and treatments while simultaneously participating in arthritis research.

Since a completely refreshed and advanced version of ArthritisPower was launched in March 2017, more than 8500 patients joined the community and have already logged more than 80,000 patient reported outcome measures.

ArthritisPower is part of PCORnet, the National Patient-Centered Clinical Research Network, developed with support from PCORI, a nonprofit, nongovernmental organization authorized by Congress in 2010. Its overall goal is to support clinical research that will enhance informed health care decision making and improve health care delivery.

CreakyJoints, now in its 18th year, is the go-to source for more than 100,000 patients with arthritis and their families worldwide who are seeking education, support, advocacy, and patient-centered research.

Having a diverse, large, and engaged patient population within ArthritisPower enhances researchers’ ability to study and better understand the arthritis community, it was noted. Researchers from elite universities and research organizations nationwide, such as Johns Hopkins University, Duke University, Yale University, and the University of Alabama at Birmingham, access the ArthritisPower research registry to inform their studies.

Resulting data are anonymized and focus on the patient experience of arthritis to better understand patient preferences related to disease management as well as with traditional and complementary therapies. Data derived from ArthritisPower have been presented at major medical meetings, such as those of the American College of Rheumatology and the European League Against Rheumatism, and are slated for future peer-reviewed publications.

“We are absolutely delighted that ArthritisPower is being actively used by thousands of arthritis patients (like me) who personally benefit from tracking and directly sharing their disease experience with their loved ones and their healthcare providers,” said Seth Ginsberg, president and co-founder of CreakyJoints and a principal investigator of ArthritisPower.


By clicking Accept, you agree to become a member of the UBM Medica Community.